Comparative study of the efficacy of short and long duration levofloxacin-rifampicin combination therapy in the treatment of early postoperative and haemotogenous staphylococcal prosthetic joint infection: a phase IV, multicentre, open trial

Trial Profile

Comparative study of the efficacy of short and long duration levofloxacin-rifampicin combination therapy in the treatment of early postoperative and haemotogenous staphylococcal prosthetic joint infection: a phase IV, multicentre, open trial

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 03 Nov 2014

At a glance

  • Drugs Levofloxacin (Primary) ; Rifampicin (Primary)
  • Indications Bone and joint infections; Postoperative infections; Staphylococcal infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Nov 2014 Status changed to discontinued as reported by EudraCT record.
    • 13 Sep 2013 Preliminary results presented at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy.
    • 13 Apr 2013 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top